TIGIT limits immune pathology during viral infections
TIGIT is a lymphocyte co-inhibitory receptor that can limit type 1 and cytotoxic T cell responses and maintain immunological tolerance. Here the authors show that TIGIT also limits immune pathology during LCMV or influenza infections in mice by driving IL-10 expression without negatively affecting t...
Saved in:
Main Authors: | Michelle Schorer, Nikolas Rakebrandt, Katharina Lambert, Annika Hunziker, Katharina Pallmer, Annette Oxenius, Anja Kipar, Silke Stertz, Nicole Joller |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/c8492053acd54e879e004b10fac09bc3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
by: Michelle Schorer, et al.
Published: (2020) -
TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
by: Paloma Riquelme, et al.
Published: (2018) -
Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing
by: Mariana Borsa, et al.
Published: (2021) -
Implication of TIGIT+ human memory B cells in immune regulation
by: Md Mahmudul Hasan, et al.
Published: (2021) -
A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
by: Ombretta Annibali, et al.
Published: (2021)